Showing results (151-160 of 227) with videos related to

Sort By:
Pageof 23
Pharmaceutical Statistics|July 24, 2009
The time course of drug effectsHesham S Al-Sallami, Venkata V Pavan Kumar, Cornelia B Landersdorfer, et al.
The New Zealand Medical Journal|August 3, 2012
Dabigatran: rational dose individualisation and monitoring guidance is neededStephen B Duffull, Daniel F B Wright, Hesham S Al-Sallami, et al.
ACS Pharmacology & Translational Science|December 16, 2022
In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1H-indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator?Hayley M Green, David B Finlay, Ruth A Ross, et al.
Drug Safety|August 3, 2019
The Association between Metformin Therapy and Lactic AcidosisIsabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 15, 2012
Serial correlation in optimal design for nonlinear mixed effects modelsJoakim Nyberg, Richard Höglund, Martin Bergstrand, et al.
The AAPS Journal|March 12, 2009
Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision makingKristin C Carlsson, Radojka M Savić, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 28, 2013
Optimizing disease progression study designs for drug effect discriminationSebastian Ueckert, Stefanie Hennig, Joakim Nyberg, et al.
Clinical Pharmacokinetics|March 14, 2013
A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cellsJulia Korell, Lisa K Stamp, Murray L Barclay, et al.
British Journal of Clinical Pharmacology|October 10, 2015
Predicting allopurinol response in patients with goutDaniel F B Wright, Stephen B Duffull, Tony R Merriman, et al.
The Journal of Pain|December 8, 2009
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalinChe S Zin, Lisa M Nissen, James P O'Callaghan, et al.
Pageof 23